Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic name for lamotrigine?Trazodone drug class?Compare pharmacy prices for eliquis?Mounjaro patent expiration in india?What is the difference between vyvanse and adderall?
See the DrugPatentWatch profile for Zepbound
Zepbound (tirzepatide) received European Medicines Agency (EMA) approval on 2023-12-21. [1]
No change is indicated for the EMA approval date itself in the available reference; the key date to track for “EMA approval date” is the original EMA authorization date. [1]
The EMA approval date is the authorization date for marketing in the EU/EEA. After that, each country still handles local steps like pricing and reimbursement, which can affect when patients can actually access the medicine. [1]
Other Questions About Zepbound :